Search all medical codes

Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; hepatitis B surface antigen

CPT4 code

Name of the Procedure:

Infectious agent antigen detection by immunoassay technique, commonly referred to as:

  • Enzyme Immunoassay (EIA)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunochemiluminometric Assay (IMCA)
  • Hepatitis B Surface Antigen Test

Summary

This procedure is a lab test used to identify the presence of the hepatitis B surface antigen (HBsAg) in a blood sample. It utilizes immunoassay techniques to detect the viral antigen, indicating an active hepatitis B infection.

Purpose

Medical Condition:
  • Hepatitis B Virus (HBV) Infection
Goals:
  • To detect active HBV infection
  • To help diagnose acute or chronic hepatitis B
  • To identify carriers of hepatitis B

Indications

  • Symptoms of hepatitis (e.g., jaundice, fatigue, abdominal pain)
  • Elevated liver enzymes (AST/ALT)
  • Routine screening in high-risk populations (e.g., healthcare workers, pregnant women)
  • Monitoring status of known HBV carriers
  • Blood donors and organ transplant candidates

Preparation

  • No special preparation is typically required.
  • Inform the healthcare provider about any medications or underlying health conditions.

Procedure Description

  1. Sample Collection: A healthcare professional will draw a blood sample from a vein, usually in the arm.
  2. Laboratory Processing:

    • The blood sample is sent to a laboratory.
    • Immunoassay techniques (EIA, ELISA, or IMCA) are used to detect the HBsAg in the blood sample.
    • Specific antibodies that bind to the HBsAg are utilized.
    • Multiple steps involve binding, washing, and detection stages to ensure specificity and accuracy.

    Tools Used:

    • Needles and syringes for blood collection
    • Laboratory assay kits specific for HBsAg detection

Anesthesia or Sedation:

  • None

Duration

  • Blood sample collection: 5-10 minutes.
  • Laboratory processing: Several hours to a few days, depending on the lab.

Setting

  • Typically done in outpatient clinics, hospitals, or specialized diagnostic labs.

Personnel

  • Phlebotomists or trained healthcare providers for blood collection
  • Laboratory technicians or medical technologists for sample analysis

Risks and Complications

  • Common: Minor discomfort or bruising at the site of blood draw
  • Rare: Infection at the puncture site, fainting or dizziness

Benefits

  • Accurate identification of active hepatitis B infection
  • Facilitates timely medical treatment and management
  • Helps prevent the spread of HBV through early detection

Recovery

  • Patients can usually return to normal activities immediately.
  • Post-procedure: Simple care for the puncture site, such as keeping it clean and covered if needed.
  • Results discussion with the healthcare provider typically follows once the analysis is complete.

Alternatives

  • HBV DNA PCR Test: Measures viral load, more detailed but typically used for ongoing monitoring rather than initial diagnosis.
  • Total anti-HBc Test: Detects previous or current HBV infection but does not differentiate between acute and chronic infection.

Pros and Cons of Alternatives:

  • HBV DNA PCR is more precise but more expensive and complex.
  • Total anti-HBc is broader but not specific for active infection.

Patient Experience

  • During the Procedure: Brief discomfort during blood draw.
  • After the Procedure: Minimal to no discomfort.
  • Pain Management: Not typically needed; over-the-counter pain relievers can be used if necessary.
  • Comfort Measures: Relaxation techniques during the blood draw, such as deep breathing.

This comprehensive guide should help patients understand the test for hepatitis B surface antigen detection by immunoassay technique and what to expect before, during, and after the procedure.

Medical Policies and Guidelines for Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; hepatitis B surface antigen

Related policies from health plans

Similar Codes